Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

534
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
534
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

5.1K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
5.1K
Types of RNA01:23

Types of RNA

69.6K
Overview
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
69.6K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

541
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
541
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

146
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
146
Antibiotic Selection00:57

Antibiotic Selection

56.7K
Overview
56.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aesthetic Treatment Considerations in Patients with Cutaneous Autoimmune Disease.

The Journal of clinical and aesthetic dermatology·2025
Same author

Ethics of reversible dermatologic care in transgender and gender-diverse adolescents under restrictive and ambiguous laws.

Clinics in dermatology·2025
Same author

An Assessment and Comparison of Adverse Effect Rates in Differing Absorbable Thread Lift Suture Materials.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]·2024
Same author

Development of an Objective Structured Assessment of Technical Skills for Sclerotherapy.

Journal of the American Academy of Dermatology·2024
Same author

Strategies for overcoming obstacles to hands-on cosmetic and laser training in dermatology residency.

Journal of the American Academy of Dermatology·2024
Same author

Acute vesiculobullous eruption in lupus patient on trimethoprim-sulfamethoxazole.

JAAD case reports·2024
Same journal

Drug-Induced Subacute Cutaneous Lupus Erythematosus Associated with Fenofibrate Lipid Lowering Agent.

Skinmed·2025
Same journal

Racial Disparities in the Management of Atopic Dermatitis: An Analysis of the National Ambulatory Medical Care Survey, 2012-2018.

Skinmed·2025
Same journal

"Pseudo-Chik Sign" Following COVID-19: Pigmentation Hitherto Unreported.

Skinmed·2025
Same journal

Hyperpigmented Scaly Lesions in the Axillae.

Skinmed·2025
Same journal

Sweet Syndrome-Like Disorder Induced by the Oxford-AstraZeneca<sup>®</sup> SARS-CoV-2 Vaccine.

Skinmed·2025
Same journal

Lockdown Lessons from Dermatology Consultations during the COVID-19 Pandemic in a Tertiary Care Center.

Skinmed·2025
See all related articles

Related Experiment Video

Updated: Oct 20, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K

Inhibition of Clostridium difficile and Antibiotic-Resistant Subtypes by Compound RNW03.

William Eng1, Robert A Norman2, Lara E Saikaly3

  • 1Department of Pathology, University of Central Florida College of Medicine, Lake Nona, FL; drwilliameng@yahoo.com.

Skinmed
|September 16, 2021
PubMed
Summary
This summary is machine-generated.

A new broad-spectrum antimicrobial, compound RNW03, effectively inhibited the growth of seven Clostridium difficile strains. This includes antibiotic-resistant C. difficile, offering potential new therapeutic options.

More Related Videos

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.8K
Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
06:42

Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance

Published on: September 27, 2024

2.2K

Related Experiment Videos

Last Updated: Oct 20, 2025

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

9.1K
Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

12.8K
Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance
06:42

Author Spotlight: Exploring the Antibacterial Effects of Zinc Oxide Nanoparticles in Overcoming Antibiotic Resistance

Published on: September 27, 2024

2.2K

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pharmacology

Background:

  • Antibiotic use disrupts gut microbiota, leading to Clostridium difficile infections.
  • Emergence of antibiotic-resistant C. difficile strains limits treatment options.
  • Novel antimicrobial agents are needed to combat resistant C. difficile.

Purpose of the Study:

  • To evaluate the efficacy of compound RNW03 against Clostridium difficile.
  • To determine if compound RNW03 can inhibit antibiotic-resistant C. difficile subtypes.

Main Methods:

  • Compound RNW03 was titrated and added to C. difficile cultures.
  • Cultures were incubated anaerobically for 48 hours.
  • Cell counts were performed to assess bacterial growth inhibition.

Main Results:

  • Compound RNW03 demonstrated effectiveness in inhibiting all seven tested C. difficile strains.
  • Inhibition was observed across a range of dilutions, from 32- to 64-fold.
  • Efficacy extended to antibiotic-resistant C. difficile strains.

Conclusions:

  • Compound RNW03 shows significant potential as a therapeutic agent against C. difficile.
  • RNW03 is effective against both susceptible and antibiotic-resistant strains of C. difficile.
  • Further research into RNW03 may lead to new treatments for C. difficile infections.